What does Pharmacie de Bavière do?

Pharmacie de Bavière is a logistics company in Liège. Public Limited, started on 21 December 1988, 1 establishment.

What is the address of Pharmacie de Bavière?

The registered office of Pharmacie de Bavière is located at Rue des Bonnes-Villes 9, 4020 Liège.

Is Pharmacie de Bavière still active?

Yes. According to the CBE (29 October 2026) Pharmacie de Bavière is active, legal situation “Normale toestand”, started on 21 December 1988.

Is Pharmacie de Bavière registered on Peppol?

Yes, Pharmacie de Bavière is registered on the Peppol network with ID 0208:0436439721.

What is the enterprise number of Pharmacie de Bavière?

The enterprise number of Pharmacie de Bavière is BE0436439721.

When was Pharmacie de Bavière founded?

Pharmacie de Bavière was founded on 21 December 1988.

Who are the directors of Pharmacie de Bavière?

According to the 2025 annual accounts, the directors of Pharmacie de Bavière are: Nicolas PUTOIS SPRL.

Is Pharmacie de Bavière a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 1988; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharmacie de Bavière make in 2025?

Pharmacie de Bavière posted a profit after taxes of € 133,763 in financial year 2025.

What is the revenue of Pharmacie de Bavière?

As a small company, Pharmacie de Bavière is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 492,145.

How much does an employee at Pharmacie de Bavière earn?

The average wage cost per full-time employee at Pharmacie de Bavière was € 57,300 in 2025: staff costs of € 194,940 for 3.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie de Bavière have?

According to the 2025 annual accounts, Pharmacie de Bavière has 3.4 full-time equivalents (FTE).

Pharmacie de Bavière (Public Limited) - Liège

Dossier Pharmacie de Bavière, printed on 29 October 2026 from databakkes.be/en/0436439721/pharmacie-de-baviere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 56 % of short-term debt in 2025; threshold 65 %.
Figures corrected NBB

Corrected annual account filed for 2025.

Financials

Financial year 2025

Pharmacie de Bavière from Liège, company number BE0436439721, closed financial year 2025 with a result of € 133,763 after tax. For that financial year Pharmacie de Bavière recorded a gross margin of € 492,145 and equity of € 294,072. Compared with financial year 2024, the result moved from € 126,092 to € 133,763. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.

What it is worth Growing

€ 294,072

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 133,763

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 52,952

▼ 46% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 110,000 paid out

82 % of the profit went to the shareholders, mostly to Nicolas PUTOIS (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

3.4

▲ 0.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 194,940

▲ 11% vs 2024

€ 57,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 108,318

▼ 10% vs 2024

Of which on lease € 90,359.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 547,254

▼ 15% vs 2024

€ 127,495 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 358,937

▲ 34% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 62,235

▼ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 338,529 Gross margin 2022: € 338,529 First fiscal year in the series	€ 385,512 Gross margin 2023: € 385,512 ▲ 14% vs 2022 (€ 338,529) Favourable step	€ 458,683 Gross margin 2024: € 458,683 ▲ 19% vs 2023 (€ 385,512) Favourable step	€ 492,145 Gross margin 2025: € 492,145 ▲ 7% vs 2024 (€ 458,683) Favourable step	▲ 7%
Profit after taxes	€ 119,813 Profit after taxes 2022: € 119,813 First fiscal year in the series	€ 102,730 Profit after taxes 2023: € 102,730 ▼ 14% vs 2022 (€ 119,813) Unfavourable step	€ 126,092 Profit after taxes 2024: € 126,092 ▲ 23% vs 2023 (€ 102,730) Favourable step	€ 133,763 Profit after taxes 2025: € 133,763 ▲ 6% vs 2024 (€ 126,092) Favourable step	▲ 6%
Equity	€ 251,487 Equity 2022: € 251,487 First fiscal year in the series	€ 254,217 Equity 2023: € 254,217 ▲ 1% vs 2022 (€ 251,487) Favourable step	€ 270,309 Equity 2024: € 270,309 ▲ 6% vs 2023 (€ 254,217) Favourable step	€ 294,072 Equity 2025: € 294,072 ▲ 9% vs 2024 (€ 270,309) Favourable step	▲ 9%
Total debts	€ 697,394 Total debts 2022: € 697,394 First fiscal year in the series	€ 1,281,560 Total debts 2023: € 1,281,560 ▲ 84% vs 2022 (€ 697,394) Unfavourable step	€ 1,100,245 Total debts 2024: € 1,100,245 ▼ 14% vs 2023 (€ 1,281,560) Favourable step	€ 1,080,391 Total debts 2025: € 1,080,391 ▼ 2% vs 2024 (€ 1,100,245) Favourable step	▼ 2%
Cash	€ 99,078 Cash 2022: € 99,078 First fiscal year in the series	€ 166,801 Cash 2023: € 166,801 ▲ 68% vs 2022 (€ 99,078) Favourable step	€ 98,487 Cash 2024: € 98,487 ▼ 41% vs 2023 (€ 166,801) Unfavourable step	€ 52,952 Cash 2025: € 52,952 ▼ 46% vs 2024 (€ 98,487) Unfavourable step	▼ 46%
Land & buildings	€ 8,197 Land & buildings 2022: € 8,197 First fiscal year in the series	€ 8,197 Land & buildings 2023: € 8,197 Unchanged (€ 8,197) Unchanged	€ 8,197 Land & buildings 2024: € 8,197 Unchanged (€ 8,197) Unchanged	€ 8,197 Land & buildings 2025: € 8,197 Unchanged (€ 8,197) Unchanged
Retained profit	€ 152,329 Retained profit 2022: € 152,329 First fiscal year in the series	€ 155,060 Retained profit 2023: € 155,060 ▲ 2% vs 2022 (€ 152,329) Favourable step	€ 171,152 Retained profit 2024: € 171,152 ▲ 10% vs 2023 (€ 155,060) Favourable step	€ 194,915 Retained profit 2025: € 194,915 ▲ 14% vs 2024 (€ 171,152) Favourable step	▲ 14%
Dividend	€ 80,000 Dividend 2022: € 80,000 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▲ 25% vs 2022 (€ 80,000) Unchanged	€ 110,000 Dividend 2024: € 110,000 ▲ 10% vs 2023 (€ 100,000) Unchanged	€ 110,000 Dividend 2025: € 110,000 Unchanged (€ 110,000) Unchanged
Bank debt	€ 306,764 Bank debt 2022: € 306,764 First fiscal year in the series	€ 740,771 Bank debt 2023: € 740,771 ▲ 141% vs 2022 (€ 306,764) Unfavourable step	€ 646,732 Bank debt 2024: € 646,732 ▼ 13% vs 2023 (€ 740,771) Favourable step	€ 547,254 Bank debt 2025: € 547,254 ▼ 15% vs 2024 (€ 646,732) Favourable step	▼ 15%
Balance sheet total	€ 948,881 Balance sheet total 2022: € 948,881 First fiscal year in the series	€ 1,535,777 Balance sheet total 2023: € 1,535,777 ▲ 62% vs 2022 (€ 948,881) Unchanged	€ 1,370,554 Balance sheet total 2024: € 1,370,554 ▼ 11% vs 2023 (€ 1,535,777) Unchanged	€ 1,374,463 Balance sheet total 2025: € 1,374,463 Unchanged (€ 1,370,554) Unchanged
Employees (FTE)	2.5 Employees (FTE) 2022: 2.5 First fiscal year in the series	2.7 Employees (FTE) 2023: 2.7 ▲ 0.2 vs 2022 (2.5) Unchanged	2.7 Employees (FTE) 2024: 2.7 Unchanged (2.7) Unchanged	3.4 Employees (FTE) 2025: 3.4 ▲ 0.7 vs 2024 (2.7) Unchanged	▲ 0.7

Key figures of Pharmacie de Bavière, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie de Bavière?

What happened at Pharmacie de Bavière in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Nicolas PUTOIS SPRL stepped down as director. NBB
Sep 28, 2026 Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
2023 Nicolas PUTOIS SPRL became a director. NBB
Feb 1, 1989 New establishment in Liège. KBO
Dec 21, 1988 Start of the company according to the CBE. KBO

In short

From € 119,813 profit in 2022 to € 133,763 profit in 2025.

Paid € 114,317 in corporate taxes since 2022.

Best year ever: 2025, with € 133,763 profit.

On average € 144,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Nicolas PUTOIS 100%

The stake of Nicolas PUTOIS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharmacie de Bavière

PGE2 50%

The shares are held by Nicolas PUTOIS (100%). It owns 50% of PGE2 itself.

Directors

According to the 2025 annual accounts

Nicolas PUTOIS SPRL

Director · represented by Nicolas PUTOIS

Also active at: PGL PHARMA

since 2023 · until 2029

Shareholders

Nicolas PUTOIS

100%

Participations

PGE2

50%

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Bonnes-Villes 9

4020 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0436.439.721

VAT number

BE 0436.439.721

Registered office

Rue des Bonnes-Villes 9, 4020 Liège

Names & denominations

Pharmacie de Bavière

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

21 December 1988

Peppol

Active · Active since 4 Nov 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie de Bavière

Warning lights

Financials

What happened to Pharmacie de Bavière?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions